| |
| | ADC -- eLetters for Singer et al., 89 (7) 595-597 |
 | | This is a common and well documented problem when using enhanced chemiluminescence (ECL) detection systems, and it is for this reason that we do not use ECL routinely in our laboratory for diagnostic screening for anti-neuronal antibodies. |
 | | Non- specific binding, however, can be reduced by optimising the quantity of protein loaded, using specialised transfer membranes, using specially formulated blocking solutions, optimising the washing steps, reducing the concentration of the second or detector antibody, using more specific detector antibodies or adding a chaotropic agent to the washing solution. |
 | | Singer and colleagues did not describe their Western blotting methods in their commentary, nor the method used to remove lipid from their basal ganglia preparation or the colorimetric agent used in the experiments in Figure 2 [1]. |
| adc.bmjjournals.com /cgi/eletters/89/7/595 (1227 words) |
|